Skip to main content

Telemedicine not favored by cancer patients or physicians

Older woman_online consultation

The majority of patients with cancer and their physicians report a preference for in-person visits rather than telemedicine consultations, suggest results of a survey carried out at the start of the COVID-19 pandemic.


Web-based program plus text messaging may help improve knee OA pain

Senior man using tablet device

A web-based exercise intervention combined with text messaging support for people with knee osteoarthritis leads to greater improvements in pain and function at 6 months than web-based information alone, Australian research shows.

Headlines from across medwireNews

23-04-2021 | Diabetes | News | Article

Pragmatic trial challenges ‘dogma’ of basal–bolus insulin for advanced type 2 diabetes

Combining a GLP-1 receptor agonist or SGLT2 inhibitor with basal insulin allows people with type 2 diabetes on a basal–bolus regimen to drop the prandial insulin, shows the pragmatic BEYOND trial.

23-04-2021 | Oncology | News | Article

Lenvatinib–everolimus has ‘encouraging activity’ in untreated non-clear cell RCC

Previously untreated patients with advanced non-clear cell renal cell carcinoma could benefit from treatment with lenvatinib plus everolimus, suggests a phase 2 study.

23-04-2021 | Rheumatology | News | Article

Treat-to-target urate lowering regimen feasible in most people with gout

A urate lowering treat-to-target approach combined with personalized advice can help the majority of patients with gout achieve satisfactory serum urate levels, but some modifiable barriers to target fulfillment still exist, Norwegian researchers report.

22-04-2021 | Oncology | News | Article

Limited evidence to link antihypertensive use to cancer

An extensive meta-analysis of individual participant data has not found consistent evidence to indicate that antihypertensive use is associated with an increased risk for cancer.

22-04-2021 | Rheumatology | News | Article

German rheumatologists encouraged to vaccinate patients against routine infections

Routine vaccination rates are currently “inacceptable” among patients with chronic inflammatory rheumatic diseases in Germany, researchers report in RMD Open.

22-04-2021 | Diabetes | News | Article

Real-world DISCOVER program highlights sulfonylurea drawbacks

Combining metformin with a sulfonylurea produces poorer non-glycemic outcomes than combining it with other second-line agents, show results from the global DISCOVER program.

medwireNews is an established provider of authoritative, timely and independent medical news. We value your feedback and encourage you to contact us to make your preferred medical news resource.

Meet the team

Image Credits